Skip to content

Clinical trials

Phase 2 Hypertension, Pulmonary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Phase 2 Clear all

131 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20042
20054
20067
20076
20088
20098
20109
20116
20127
20133
20144
20153
20165
20176
20184
20196
20204
20213
20226
20233
20244
20258
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed61
Terminated35
Recruiting12
Withdrawn9
Unknown status6
Active, not recruiting5
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion7
Bayer7
Novartis Pharmaceuticals5
Gilead Sciences4
GlaxoSmithKline4
Bastiaan Driehuys3
Heidelberg University3
United Therapeutics3
University of Pennsylvania3
VA Office of Research and Development3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary131
Pulmonary Arterial Hypertension38
Lung Diseases, Interstitial11
Pulmonary Disease, Chronic Obstructive10
Familial Primary Pulmonary Hypertension8
Pulmonary Fibrosis8
Anemia, Sickle Cell6
Heart Failure6
Lung Diseases6
Cardiovascular Diseases5

Trials

Showing 76 to 100 of 131. Each trial links to its page on Pharma Observatory.

31 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.